Andrew J. Fromkin - Net Worth and Insider Trading

Andrew J. Fromkin Net Worth

The estimated net worth of Andrew J. Fromkin is at least $3 Million dollars as of 2024-11-13. Andrew J. Fromkin is the Director of Immunovant Inc and owns about 88,658 shares of Immunovant Inc (IMVT) stock worth over $3 Million. Details can be seen in Andrew J. Fromkin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew J. Fromkin has not made any transactions after 2023-12-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Andrew J. Fromkin

To

Andrew J. Fromkin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Andrew J. Fromkin owns 4 companies in total, including Immunovant Inc (IMVTU) , Regado Biosciences Inc (RGDO) , and Radius Health Inc (RDUS) among others .

Click here to see the complete history of Andrew J. Fromkin’s form 4 insider trades.

Insider Ownership Summary of Andrew J. Fromkin

Ticker Comapny Transaction Date Type of Owner
IMVTU Immunovant Inc 2020-05-15 director
RGDO Regado Biosciences Inc 2016-11-01 director
RDUS Radius Health Inc 2013-11-12 director & President & CEO
LIMIT LIMIT 2023-12-01 director

Andrew J. Fromkin Latest Holdings Summary

Andrew J. Fromkin currently owns a total of 1 stock. Andrew J. Fromkin owns 88,658 shares of Immunovant Inc (IMVT) as of December 1, 2023, with a value of $3 Million.

Latest Holdings of Andrew J. Fromkin

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
IMVT Immunovant Inc 2023-12-01 88,658 29.27 2,595,020

Holding Weightings of Andrew J. Fromkin


Andrew J. Fromkin Form 4 Trading Tracker

According to the SEC Form 4 filings, Andrew J. Fromkin has made a total of 2 transactions in Immunovant Inc (IMVT) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Immunovant Inc is the sale of 12,350 shares on December 1, 2023, which brought Andrew J. Fromkin around $490,666.

Insider Trading History of Andrew J. Fromkin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Andrew J. Fromkin Trading Performance

GuruFocus tracks the stock performance after each of Andrew J. Fromkin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew J. Fromkin is 7.42%. GuruFocus also compares Andrew J. Fromkin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew J. Fromkin within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Andrew J. Fromkin's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Andrew J. Fromkin

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 6.55 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 6.06 LIMIT LIMIT LIMIT LIMIT LIMIT

Andrew J. Fromkin Ownership Network

Ownership Network List of Andrew J. Fromkin

No Data

Ownership Network Relation of Andrew J. Fromkin

Insider Network Chart

Andrew J. Fromkin Owned Company Details

What does Immunovant Inc do?

Who are the key executives at Immunovant Inc?

Andrew J. Fromkin is the director of Immunovant Inc. Other key executives at Immunovant Inc include 10 percent owner Roivant Sciences Ltd. , Chief Dev. & Tech. Officer Julia G. Butchko , and Chief Scientific Officer Michael James Elliott .

Immunovant Inc (IMVTU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Immunovant Inc (IMVTU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immunovant Inc (IMVTU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Immunovant Inc (IMVTU)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Immunovant Inc Insider Transactions

No Available Data

Andrew J. Fromkin Mailing Address

Above is the net worth, insider trading, and ownership report for Andrew J. Fromkin. You might contact Andrew J. Fromkin via mailing address: C/o Radius Health, Inc., 201 Broadway, 6th Fl, Cambridge Ma 02139.